arrow
B

Besnik Qeriqi

Memorial Sloan Kettering Cancer Center
H指数:10
被引数:2,038

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma

同时抑制SOS1和MEK抑制NF1-null黑色素瘤的信号传导和生长

2024-11-010
OAAI
Molecular Characterization of Acquired Resistance to KRAS G12C-EGFR Inhibition in Colorectal Cancer
2022-11-1047
OAAI
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy
2020-11-16126
OAAI
HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers
2020-05-01188
OAAI
EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

EGFR和MET扩增决定了ERBB2-Amplified食管胃癌对HER2抑制的反应

2019-02-08127
OAAI
RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling

RAF抑制剂PLX8394选择性破坏BRAF二聚体和RAS非依赖性BRAF突变体驱动的信号传导

2018-12-17146
OAAI